Treatment of four GCB-DLBCL lines with cycloheximide confirmed the half-life of MCL-1 to be approximately 90 minutes (Supplemental Figure 5E), in agreement with previous studies [44]. This evidence concerns the gene MCL1 and diffuse large B-cell lymphoma.